Skip to main content

Structural Genomix in $11M Deal with Cystic Fibrosis Foundation

NEW YORK, Feb 8 - Structural Genomix said Thursday it reached an agreement with the Cystic Fibrosis Foundation to determine the structure of a protein, cystic fibrosis transmembrane regulator, which is involved in causing cystic fibrosis.

" CF scientists have attempted to determine the structure of the CFTR protein, but without a lot of success. The CF Foundation thinks that Structural Genomix will bring new cutting edge technologies to the problem, and hopefully accomplish this difficult task," Robert Beall, CEO of the Cystic Fibrosis Foundation, said in a statement.

Under the terms of the five-year deal, the Cystic Fibrosis Foundation will give $11 million to Structural Genomix in research funding and will pay additional milestone and royalty payments.

Structural Genomix, which employs x-ray crystallography to determine protein structures, will study sequence variations in the CFTR gene across species to determine the x-ray structure of the protein. A defective gene that codes for the CFTR protein causes the development of a thick mucus that damages airways and the digestive tract and leads to a host of infectious diseases.

The company said that no 3-D structure of CFTR currently exists.

Structural Genomix of San Diego and the Cystic Fibrosis Foundation hope that by understanding the structure of CFTR, drug makers will be able to develop new compounds and therapies for cystic fibrosis.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.